Drug Type Small molecule drug |
Synonyms FCE-28260, FCE-29330, FCE-29331 + [1] |
Target |
Action inhibitors |
Mechanism 5α-reductase inhibitors(Steroid 5 alpha reductase inhibitors) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
License Organization- |
Drug Highest PhaseDiscontinuedDiscovery |
First Approval Date- |
Regulation- |
Molecular FormulaC28H35F3N2O2 |
InChIKeyFAIZUAWLKOHMOP-ZOIXLQFFSA-N |
CAS Registry155651-56-2 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Acne Vulgaris | Discovery | United Kingdom | - | |
Alopecia | Discovery | United Kingdom | - | |
Breast Cancer | Discovery | United Kingdom | - | |
Hirsutism | Discovery | United Kingdom | - | |
Prostatic Cancer | Discovery | United Kingdom | - | |
Prostatic Hyperplasia | Discovery | United Kingdom | - |